SOX2 and prostate carcinoma: The analysis of the SOX2 and OCT4 expression in PC3 cells showed that the SORE6+ cell population expressed more of these proteins than the SORE6− population did (Figure 1C,D), indicating that the SORE6 reporter can identify prostate cancer cells overexpressing SOX2 and OCT4.